PL
BBIO icon

Perpetual Ltd’s BridgeBio Pharma BBIO Stock Holding History

Perpetual Ltd’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Buy
+8,583
New +$601K 0.01% 287

Other funds holding BBIO

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Perpetual Ltd's BBIO Position: Q2 2026 in Review

Perpetual Ltd opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 8,583 shares worth $639K. The stake represents 0.01% of the portfolio and ranks #287 among its holdings.

36 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Perpetual Ltd held 8,583 shares of BridgeBio Pharma worth $639K as of Q2 2026.
  • BridgeBio Pharma was a new Perpetual Ltd position in Q2 2026.
  • BridgeBio Pharma made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #287 holding.
  • 36 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.